APO Research
Talk to an analyst

APO RESEARCH · REPORT

Food Immunomodulator

Compare research editions
View pricing & licenses

Selected research

Industry Research

Food Immunomodulator Industry Research Report 2026

1 January 2026146 pages

Choose your research edition.

Industry ResearchFood Immunomodulator Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Food Immunomodulator Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Food Immunomodulator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Food Immunomodulator Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Food Immunomodulator Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Food Immunomodulator market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Food Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Food Immunomodulator is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Food Immunomodulator is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Food Immunomodulator include Danone SA, Nestle SA, Yakult Honsha Co.. Ltd., ADM, Kerry Group, Cargill Inc., IFF, DSM and Chr Hansen Holding A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Food Immunomodulator market in terms of revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Food Immunomodulator Market by Company

Danone SA

Nestle SA

Yakult Honsha Co.. Ltd.

ADM

Kerry Group

Cargill Inc.

IFF

DSM

Chr Hansen Holding A/S

Ingredion inc.

Sabinsa Corporation

BASF

Lonza

BioGaia

Lallemand Inc.

Tate and Lyle

Glanbia Nutritionals

Symbiotec

Amway Corporation

Bio-Thera Solutions Ltd.

Stratu

Nutrition

Food Immunomodulator Segment by Type

Powder

Tablets

Capsules

Other

Food Immunomodulator Segment by Application

Supermarket

Specialty Store

Online Sales

Other

Food Immunomodulator Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Food Immunomodulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Food Immunomodulator and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Food Immunomodulator.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Food Immunomodulator manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Food Immunomodulator by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Food Immunomodulator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Food Immunomodulator Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Food Immunomodulator Sales (kt) of Manufacturers (2021-2026) Table 7. Global Food Immunomodulator Sales Market Share by Manufacturers (2021-2026) Table 8. Global Food Immunomodulator Revenue of Manufacturers (2021-2026) Table 9. Global Food Immunomodulator Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Food Immunomodulator Average Price (USD/t) of Manufacturers (2021-2026) Table 11. Global Food Immunomodulator Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Food Immunomodulator, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Food Immunomodulator, Product Type & Application Table 14. Global Food Immunomodulator Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Food Immunomodulator by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Danone SA Company Information Table 19. Danone SA Business Overview Table 20. Danone SA Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 21. Danone SA Food Immunomodulator Product Portfolio Table 22. Danone SA Recent Developments Table 23. Nestle SA Company Information Table 24. Nestle SA Business Overview Table 25. Nestle SA Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 26. Nestle SA Food Immunomodulator Product Portfolio Table 27. Nestle SA Recent Developments Table 28. Yakult Honsha Co.. Ltd. Company Information Table 29. Yakult Honsha Co.. Ltd. Business Overview Table 30. Yakult Honsha Co.. Ltd. Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 31. Yakult Honsha Co.. Ltd. Food Immunomodulator Product Portfolio Table 32. Yakult Honsha Co.. Ltd. Recent Developments Table 33. ADM Company Information Table 34. ADM Business Overview Table 35. ADM Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 36. ADM Food Immunomodulator Product Portfolio Table 37. ADM Recent Developments Table 38. Kerry Group Company Information Table 39. Kerry Group Business Overview Table 40. Kerry Group Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 41. Kerry Group Food Immunomodulator Product Portfolio Table 42. Kerry Group Recent Developments Table 43. Cargill Inc. Company Information Table 44. Cargill Inc. Business Overview Table 45. Cargill Inc. Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 46. Cargill Inc. Food Immunomodulator Product Portfolio Table 47. Cargill Inc. Recent Developments Table 48. IFF Company Information Table 49. IFF Business Overview Table 50. IFF Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 51. IFF Food Immunomodulator Product Portfolio Table 52. IFF Recent Developments Table 53. DSM Company Information Table 54. DSM Business Overview Table 55. DSM Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 56. DSM Food Immunomodulator Product Portfolio Table 57. DSM Recent Developments Table 58. Chr Hansen Holding A/S Company Information Table 59. Chr Hansen Holding A/S Business Overview Table 60. Chr Hansen Holding A/S Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 61. Chr Hansen Holding A/S Food Immunomodulator Product Portfolio Table 62. Chr Hansen Holding A/S Recent Developments Table 63. Ingredion inc. Company Information Table 64. Ingredion inc. Business Overview Table 65. Ingredion inc. Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 66. Ingredion inc. Food Immunomodulator Product Portfolio Table 67. Ingredion inc. Recent Developments Table 68. Sabinsa Corporation Company Information Table 69. Sabinsa Corporation Business Overview Table 70. Sabinsa Corporation Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. Sabinsa Corporation Food Immunomodulator Product Portfolio Table 72. Sabinsa Corporation Recent Developments Table 73. BASF Company Information Table 74. BASF Business Overview Table 75. BASF Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. BASF Food Immunomodulator Product Portfolio Table 77. BASF Recent Developments Table 78. Lonza Company Information Table 79. Lonza Business Overview Table 80. Lonza Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Lonza Food Immunomodulator Product Portfolio Table 82. Lonza Recent Developments Table 83. BioGaia Company Information Table 84. BioGaia Business Overview Table 85. BioGaia Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. BioGaia Food Immunomodulator Product Portfolio Table 87. BioGaia Recent Developments Table 88. Lallemand Inc. Company Information Table 89. Lallemand Inc. Business Overview Table 90. Lallemand Inc. Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Lallemand Inc. Food Immunomodulator Product Portfolio Table 92. Lallemand Inc. Recent Developments Table 93. Tate and Lyle Company Information Table 94. Tate and Lyle Business Overview Table 95. Tate and Lyle Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Tate and Lyle Food Immunomodulator Product Portfolio Table 97. Tate and Lyle Recent Developments Table 98. Glanbia Nutritionals Company Information Table 99. Glanbia Nutritionals Business Overview Table 100. Glanbia Nutritionals Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Glanbia Nutritionals Food Immunomodulator Product Portfolio Table 102. Glanbia Nutritionals Recent Developments Table 103. Symbiotec Company Information Table 104. Symbiotec Business Overview Table 105. Symbiotec Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Symbiotec Food Immunomodulator Product Portfolio Table 107. Symbiotec Recent Developments Table 108. Amway Corporation Company Information Table 109. Amway Corporation Business Overview Table 110. Amway Corporation Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. Amway Corporation Food Immunomodulator Product Portfolio Table 112. Amway Corporation Recent Developments Table 113. Bio-Thera Solutions Ltd. Company Information Table 114. Bio-Thera Solutions Ltd. Business Overview Table 115. Bio-Thera Solutions Ltd. Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 116. Bio-Thera Solutions Ltd. Food Immunomodulator Product Portfolio Table 117. Bio-Thera Solutions Ltd. Recent Developments Table 118. Stratu Company Information Table 119. Stratu Business Overview Table 120. Stratu Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 121. Stratu Food Immunomodulator Product Portfolio Table 122. Stratu Recent Developments Table 123. Nutrition Company Information Table 124. Nutrition Business Overview Table 125. Nutrition Food Immunomodulator Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 126. Nutrition Food Immunomodulator Product Portfolio Table 127. Nutrition Recent Developments Table 128. Global Food Immunomodulator Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 129. Global Food Immunomodulator Sales by Region (2021-2026) & (kt) Table 130. Global Food Immunomodulator Sales Market Share by Region (2021-2026) Table 131. Global Food Immunomodulator Sales by Region (2027-2032) & (kt) Table 132. Global Food Immunomodulator Sales Market Share by Region (2027-2032) Table 133. Global Food Immunomodulator Revenue by Region (2021-2026) & (US$ Million) Table 134. Global Food Immunomodulator Revenue Market Share by Region (2021-2026) Table 135. Global Food Immunomodulator Revenue by Region (2027-2032) & (US$ Million) Table 136. Global Food Immunomodulator Revenue Market Share by Region (2027-2032) Table 137. North America Food Immunomodulator Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. North America Food Immunomodulator Sales by Country (2021-2026) & (kt) Table 139. North America Food Immunomodulator Sales by Country (2027-2032) & (kt) Table 140. North America Food Immunomodulator Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Food Immunomodulator Revenue by Country (2027-2032) & (US$ Million) Table 142. Europe Food Immunomodulator Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Europe Food Immunomodulator Sales by Country (2021-2026) & (kt) Table 144. Europe Food Immunomodulator Sales by Country (2027-2032) & (kt) Table 145. Europe Food Immunomodulator Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Food Immunomodulator Revenue by Country (2027-2032) & (US$ Million) Table 147. Asia Pacific Food Immunomodulator Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Asia Pacific Food Immunomodulator Sales by Country (2021-2026) & (kt) Table 149. Asia Pacific Food Immunomodulator Sales by Country (2027-2032) & (kt) Table 150. Asia Pacific Food Immunomodulator Revenue by Country (2021-2026) & (US$ Million) Table 151. Asia Pacific Food Immunomodulator Revenue by Country (2027-2032) & (US$ Million) Table 152. South America Food Immunomodulator Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. South America Food Immunomodulator Sales by Country (2021-2026) & (kt) Table 154. South America Food Immunomodulator Sales by Country (2027-2032) & (kt) Table 155. South America Food Immunomodulator Revenue by Country (2021-2026) & (US$ Million) Table 156. South America Food Immunomodulator Revenue by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Food Immunomodulator Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Middle East and Africa Food Immunomodulator Sales by Country (2021-2026) & (kt) Table 159. Middle East and Africa Food Immunomodulator Sales by Country (2027-2032) & (kt) Table 160. Middle East and Africa Food Immunomodulator Revenue by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Food Immunomodulator Revenue by Country (2027-2032) & (US$ Million) Table 162. Global Food Immunomodulator Sales by Type (2021-2026) & (kt) Table 163. Global Food Immunomodulator Sales by Type (2027-2032) & (kt) Table 164. Global Food Immunomodulator Sales Market Share by Type (2021-2026) Table 165. Global Food Immunomodulator Sales Market Share by Type (2027-2032) Table 166. Global Food Immunomodulator Revenue by Type (2021-2026) & (US$ Million) Table 167. Global Food Immunomodulator Revenue by Type (2027-2032) & (US$ Million) Table 168. Global Food Immunomodulator Revenue Market Share by Type (2021-2026) Table 169. Global Food Immunomodulator Revenue Market Share by Type (2027-2032) Table 170. Global Food Immunomodulator Price by Type (2021-2026) & (USD/t) Table 171. Global Food Immunomodulator Price by Type (2027-2032) & (USD/t) Table 172. Global Food Immunomodulator Sales by Application (2021-2026) & (kt) Table 173. Global Food Immunomodulator Sales by Application (2027-2032) & (kt) Table 174. Global Food Immunomodulator Sales Market Share by Application (2021-2026) Table 175. Global Food Immunomodulator Sales Market Share by Application (2027-2032) Table 176. Global Food Immunomodulator Revenue by Application (2021-2026) & (US$ Million) Table 177. Global Food Immunomodulator Revenue by Application (2027-2032) & (US$ Million) Table 178. Global Food Immunomodulator Revenue Market Share by Application (2021-2026) Table 179. Global Food Immunomodulator Revenue Market Share by Application (2027-2032) Table 180. Global Food Immunomodulator Price by Application (2021-2026) & (USD/t) Table 181. Global Food Immunomodulator Price by Application (2027-2032) & (USD/t) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Food Immunomodulator Distributors List Table 185. Food Immunomodulator Customers List Table 186. Food Immunomodulator Industry Trends Table 187. Food Immunomodulator Industry Drivers Table 188. Food Immunomodulator Industry Restraints Table 189. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Food Immunomodulator Product Image Figure 5. Global Food Immunomodulator Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Food Immunomodulator Market Size (2021-2032) & (US$ Million) Figure 7. Global Food Immunomodulator Sales (2021-2032) & (kt) Figure 8. Global Food Immunomodulator Average Price (USD/t) & (2021-2032) Figure 9. Powder Product Image Figure 10. Tablets Product Image Figure 11. Capsules Product Image Figure 12. Other Product Image Figure 13. Supermarket Product Image Figure 14. Specialty Store Product Image Figure 15. Online Sales Product Image Figure 16. Other Product Image Figure 17. Global Food Immunomodulator Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Food Immunomodulator, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Food Immunomodulator Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Food Immunomodulator Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Food Immunomodulator Sales by Region in 2025 Figure 23. Global Food Immunomodulator Revenue by Region in 2025 Figure 24. North America Food Immunomodulator Market Size by Country in 2025 Figure 25. North America Food Immunomodulator Sales Market Share by Country (2021-2032) Figure 26. North America Food Immunomodulator Revenue Market Share by Country (2021-2032) Figure 27. United States Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Food Immunomodulator Market Size by Country in 2025 Figure 31. Europe Food Immunomodulator Sales Market Share by Country (2021-2032) Figure 32. Europe Food Immunomodulator Revenue Market Share by Country (2021-2032) Figure 33. Germany Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Food Immunomodulator Market Size by Country in 2025 Figure 44. Asia Pacific Food Immunomodulator Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Food Immunomodulator Revenue Market Share by Country (2021-2032) Figure 46. China Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Food Immunomodulator Market Size by Country in 2025 Figure 55. South America Food Immunomodulator Sales Market Share by Country (2021-2032) Figure 56. South America Food Immunomodulator Revenue Market Share by Country (2021-2032) Figure 57. Brazil Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Food Immunomodulator Market Size by Country in 2025 Figure 61. Middle East and Africa Food Immunomodulator Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Food Immunomodulator Revenue Market Share by Country (2021-2032) Figure 63. Egypt Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Food Immunomodulator Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Food Immunomodulator Sales Market Share by Type (2021-2032) Figure 69. Global Food Immunomodulator Revenue Market Share by Type (2021-2032) Figure 70. Global Food Immunomodulator Price (USD/t) by Type (2021-2032) Figure 71. Global Food Immunomodulator Sales Market Share by Application (2021-2032) Figure 72. Global Food Immunomodulator Revenue Market Share by Application (2021-2032) Figure 73. Global Food Immunomodulator Price (USD/t) by Application (2021-2032) Figure 74. Food Immunomodulator Value Chain Figure 75. Food Immunomodulator Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Food Immunomodulator Industry Opportunities and Challenges

Scope & coverage.

Types
  • Powder
  • Tablets
  • Capsules
  • Other
Applications
  • Supermarket
  • Specialty Store
  • Online Sales
  • Other
Companies covered
  • Danone SA
  • Nestle SA
  • Yakult Honsha Co.. Ltd.
  • ADM
  • Kerry Group
  • Cargill Inc.
  • IFF
  • DSM
  • Chr Hansen Holding A/S
  • Ingredion inc.
  • Sabinsa Corporation
  • BASF
  • Lonza
  • BioGaia
  • Lallemand Inc.
  • Tate and Lyle
  • Glanbia Nutritionals
  • Symbiotec
  • Amway Corporation
  • Bio-Thera Solutions Ltd.
  • Stratu
  • Nutrition

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Food Immunomodulator Market Size (2021-2032)
  4. 2.2.2 Global Food Immunomodulator Sales (2021-2032)
  5. 2.2.3 Global Food Immunomodulator Market Average Price (2021-2032)
  6. 2.3 Food Immunomodulator by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Powder
  9. 2.3.3 Tablets
  10. 2.3.4 Capsules
  11. 2.3.5 Other
  12. 2.4 Food Immunomodulator by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Supermarket
  15. 2.4.3 Specialty Store
  16. 2.4.4 Online Sales
  17. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Food Immunomodulator Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Food Immunomodulator Sales (kt) of Manufacturers (2021-2026)
  3. 3.3 Global Food Immunomodulator Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Food Immunomodulator Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Food Immunomodulator Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Food Immunomodulator, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Food Immunomodulator, Product Type & Application
  8. 3.8 Global Manufacturers of Food Immunomodulator, Established Date
  9. 3.9 Global Food Immunomodulator Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Danone SA
  2. 4.1.1 Danone SA Company Information
  3. 4.1.2 Danone SA Business Overview
  4. 4.1.3 Danone SA Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Danone SA Food Immunomodulator Product Portfolio
  6. 4.1.5 Danone SA Recent Developments
  7. 4.2 Nestle SA
  8. 4.2.1 Nestle SA Company Information
  9. 4.2.2 Nestle SA Business Overview
  10. 4.2.3 Nestle SA Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Nestle SA Food Immunomodulator Product Portfolio
  12. 4.2.5 Nestle SA Recent Developments
  13. 4.3 Yakult Honsha Co.. Ltd.
  14. 4.3.1 Yakult Honsha Co.. Ltd. Company Information
  15. 4.3.2 Yakult Honsha Co.. Ltd. Business Overview
  16. 4.3.3 Yakult Honsha Co.. Ltd. Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Yakult Honsha Co.. Ltd. Food Immunomodulator Product Portfolio
  18. 4.3.5 Yakult Honsha Co.. Ltd. Recent Developments
  19. 4.4 ADM
  20. 4.4.1 ADM Company Information
  21. 4.4.2 ADM Business Overview
  22. 4.4.3 ADM Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 ADM Food Immunomodulator Product Portfolio
  24. 4.4.5 ADM Recent Developments
  25. 4.5 Kerry Group
  26. 4.5.1 Kerry Group Company Information
  27. 4.5.2 Kerry Group Business Overview
  28. 4.5.3 Kerry Group Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Kerry Group Food Immunomodulator Product Portfolio
  30. 4.5.5 Kerry Group Recent Developments
  31. 4.6 Cargill Inc.
  32. 4.6.1 Cargill Inc. Company Information
  33. 4.6.2 Cargill Inc. Business Overview
  34. 4.6.3 Cargill Inc. Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Cargill Inc. Food Immunomodulator Product Portfolio
  36. 4.6.5 Cargill Inc. Recent Developments
  37. 4.7 IFF
  38. 4.7.1 IFF Company Information
  39. 4.7.2 IFF Business Overview
  40. 4.7.3 IFF Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 IFF Food Immunomodulator Product Portfolio
  42. 4.7.5 IFF Recent Developments
  43. 4.8 DSM
  44. 4.8.1 DSM Company Information
  45. 4.8.2 DSM Business Overview
  46. 4.8.3 DSM Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 DSM Food Immunomodulator Product Portfolio
  48. 4.8.5 DSM Recent Developments
  49. 4.9 Chr Hansen Holding A/S
  50. 4.9.1 Chr Hansen Holding A/S Company Information
  51. 4.9.2 Chr Hansen Holding A/S Business Overview
  52. 4.9.3 Chr Hansen Holding A/S Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Chr Hansen Holding A/S Food Immunomodulator Product Portfolio
  54. 4.9.5 Chr Hansen Holding A/S Recent Developments
  55. 4.10 Ingredion inc.
  56. 4.10.1 Ingredion inc. Company Information
  57. 4.10.2 Ingredion inc. Business Overview
  58. 4.10.3 Ingredion inc. Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Ingredion inc. Food Immunomodulator Product Portfolio
  60. 4.10.5 Ingredion inc. Recent Developments
  61. 4.11 Sabinsa Corporation
  62. 4.11.1 Sabinsa Corporation Company Information
  63. 4.11.2 Sabinsa Corporation Business Overview
  64. 4.11.3 Sabinsa Corporation Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sabinsa Corporation Food Immunomodulator Product Portfolio
  66. 4.11.5 Sabinsa Corporation Recent Developments
  67. 4.12 BASF
  68. 4.12.1 BASF Company Information
  69. 4.12.2 BASF Business Overview
  70. 4.12.3 BASF Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 BASF Food Immunomodulator Product Portfolio
  72. 4.12.5 BASF Recent Developments
  73. 4.13 Lonza
  74. 4.13.1 Lonza Company Information
  75. 4.13.2 Lonza Business Overview
  76. 4.13.3 Lonza Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Lonza Food Immunomodulator Product Portfolio
  78. 4.13.5 Lonza Recent Developments
  79. 4.14 BioGaia
  80. 4.14.1 BioGaia Company Information
  81. 4.14.2 BioGaia Business Overview
  82. 4.14.3 BioGaia Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 BioGaia Food Immunomodulator Product Portfolio
  84. 4.14.5 BioGaia Recent Developments
  85. 4.15 Lallemand Inc.
  86. 4.15.1 Lallemand Inc. Company Information
  87. 4.15.2 Lallemand Inc. Business Overview
  88. 4.15.3 Lallemand Inc. Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Lallemand Inc. Food Immunomodulator Product Portfolio
  90. 4.15.5 Lallemand Inc. Recent Developments
  91. 4.16 Tate and Lyle
  92. 4.16.1 Tate and Lyle Company Information
  93. 4.16.2 Tate and Lyle Business Overview
  94. 4.16.3 Tate and Lyle Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Tate and Lyle Food Immunomodulator Product Portfolio
  96. 4.16.5 Tate and Lyle Recent Developments
  97. 4.17 Glanbia Nutritionals
  98. 4.17.1 Glanbia Nutritionals Company Information
  99. 4.17.2 Glanbia Nutritionals Business Overview
  100. 4.17.3 Glanbia Nutritionals Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Glanbia Nutritionals Food Immunomodulator Product Portfolio
  102. 4.17.5 Glanbia Nutritionals Recent Developments
  103. 4.18 Symbiotec
  104. 4.18.1 Symbiotec Company Information
  105. 4.18.2 Symbiotec Business Overview
  106. 4.18.3 Symbiotec Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Symbiotec Food Immunomodulator Product Portfolio
  108. 4.18.5 Symbiotec Recent Developments
  109. 4.19 Amway Corporation
  110. 4.19.1 Amway Corporation Company Information
  111. 4.19.2 Amway Corporation Business Overview
  112. 4.19.3 Amway Corporation Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Amway Corporation Food Immunomodulator Product Portfolio
  114. 4.19.5 Amway Corporation Recent Developments
  115. 4.20 Bio-Thera Solutions Ltd.
  116. 4.20.1 Bio-Thera Solutions Ltd. Company Information
  117. 4.20.2 Bio-Thera Solutions Ltd. Business Overview
  118. 4.20.3 Bio-Thera Solutions Ltd. Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Bio-Thera Solutions Ltd. Food Immunomodulator Product Portfolio
  120. 4.20.5 Bio-Thera Solutions Ltd. Recent Developments
  121. 4.21 Stratu
  122. 4.21.1 Stratu Company Information
  123. 4.21.2 Stratu Business Overview
  124. 4.21.3 Stratu Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Stratu Food Immunomodulator Product Portfolio
  126. 4.21.5 Stratu Recent Developments
  127. 4.22 Nutrition
  128. 4.22.1 Nutrition Company Information
  129. 4.22.2 Nutrition Business Overview
  130. 4.22.3 Nutrition Food Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Nutrition Food Immunomodulator Product Portfolio
  132. 4.22.5 Nutrition Recent Developments
5 Global Food Immunomodulator Market Scenario by Region
  1. 5.1 Global Food Immunomodulator Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Food Immunomodulator Sales by Region: 2021-2032
  3. 5.2.1 Global Food Immunomodulator Sales by Region: 2021-2026
  4. 5.2.2 Global Food Immunomodulator Sales by Region: 2027-2032
  5. 5.3 Global Food Immunomodulator Revenue by Region: 2021-2032
  6. 5.3.1 Global Food Immunomodulator Revenue by Region: 2021-2026
  7. 5.3.2 Global Food Immunomodulator Revenue by Region: 2027-2032
  8. 5.4 North America Food Immunomodulator Market Facts & Figures by Country
  9. 5.4.1 North America Food Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Food Immunomodulator Sales by Country (2021-2032)
  11. 5.4.3 North America Food Immunomodulator Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Food Immunomodulator Market Facts & Figures by Country
  16. 5.5.1 Europe Food Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Food Immunomodulator Sales by Country (2021-2032)
  18. 5.5.3 Europe Food Immunomodulator Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Food Immunomodulator Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Food Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Food Immunomodulator Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Food Immunomodulator Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Food Immunomodulator Market Facts & Figures by Country
  41. 5.7.1 South America Food Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Food Immunomodulator Sales by Country (2021-2032)
  43. 5.7.3 South America Food Immunomodulator Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Food Immunomodulator Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Food Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Food Immunomodulator Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Food Immunomodulator Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Food Immunomodulator Sales by Type (2021-2032)
  2. 6.1.1 Global Food Immunomodulator Sales by Type (2021-2032) & (kt)
  3. 6.1.2 Global Food Immunomodulator Sales Market Share by Type (2021-2032)
  4. 6.2 Global Food Immunomodulator Revenue by Type (2021-2032)
  5. 6.2.1 Global Food Immunomodulator Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Food Immunomodulator Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Food Immunomodulator Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Food Immunomodulator Sales by Application (2021-2032)
  2. 7.1.1 Global Food Immunomodulator Sales by Application (2021-2032) & (kt)
  3. 7.1.2 Global Food Immunomodulator Sales Market Share by Application (2021-2032)
  4. 7.2 Global Food Immunomodulator Revenue by Application (2021-2032)
  5. 7.2.1 Global Food Immunomodulator Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Food Immunomodulator Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Food Immunomodulator Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Food Immunomodulator Value Chain Analysis
  2. 8.1.1 Food Immunomodulator Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Food Immunomodulator Production Mode & Process
  5. 8.2 Food Immunomodulator Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Food Immunomodulator Distributors
  8. 8.2.3 Food Immunomodulator Customers
9 Global Food Immunomodulator Analyzing Market Dynamics
  1. 9.1 Food Immunomodulator Industry Trends
  2. 9.2 Food Immunomodulator Industry Drivers
  3. 9.3 Food Immunomodulator Industry Opportunities and Challenges
  4. 9.4 Food Immunomodulator Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst